Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules.

Autor: Liss MA; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Dursun F; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Hackman GL; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., Gadallah MI; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA.; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt., Saha A; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Friedman CA; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Rathore AS; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., Chandra P; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., White JR; Resphera Biosciences, USA., Tiziani S; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA.; Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, 78723, USA., DiGiovanni J; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA.; Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, 78723, USA.; Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, TX, USA.

Publikováno v: Journal of traditional and complementary medicine [J Tradit Complement Med] 2024 Mar 07; Vol. 14 (5), pp. 558-567. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).

Enzymatic depletion of l-Met using an engineered human enzyme as a novel therapeutic strategy for melanoma.

Autor: Wilder CS; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA., Chiou J; Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, USA., Battenhouse A; Center for Biomedical Research Support, The University of Texas at Austin, Austin, Texas, USA., Saha A; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA., Chen Z; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA., Kim E; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA., Gadallah MI; Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, USA.; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt., Tiziani S; Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, Texas, USA., Georgiou G; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, Texas, USA.; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.; Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas, USA.; Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA., Stone E; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, Texas, USA.; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA., DiGiovanni J; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, Texas, USA.; Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.; Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, Texas, USA.

Publikováno v: Molecular carcinogenesis [Mol Carcinog] 2023 Oct; Vol. 62 (10), pp. 1531-1545. Date of Electronic Publication: 2023 Jun 28.

Corrigendum to "Development and validation of a novel evaporation setup-assisted TLC method with fluorescence detection for determination of flibanserin in pharmaceutical and biological samples" [J. Chromatogr. B 1195 (2022) 123204].

Autor: Hosny NM; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. Electronic address: noha.hosni@aun.edu.eg., Abdelkarim M; Department of Mechanical Power Engineering, Faculty of Engineering, Assiut University, Assiut 71515, Egypt. Electronic address: mahmoudsalah@aun.edu.eg., Gadallah MI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. Electronic address: mohamedabrahim@pharm.aun.edu.eg., Mousa HS; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt. Electronic address: Heba.salah@svu.edu.eg.

Publikováno v: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2022 Nov 15; Vol. 1211, pp. 123479. Date of Electronic Publication: 2022 Sep 26.

Innovative computationally designed-spectrofluorimetric method for determination of modafinil in tablets and human plasma.

Autor: Hosny NM; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt. Electronic address: noha.hosni@aun.edu.eg., Gadallah MI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt; Department of Nutritional Sciences, School of Human Ecology, University of Texas at Austin, Austin, TX 78712, USA. Electronic address: mohamedabrahim@pharm.aun.edu.eg., Gomila RM; Department of Chemistry, Universitat de les Illes Balears, Crta de Valldemossa km 7.5, 07122, Palma de Mallorca (Baleares), Spain. Electronic address: rosa.gomila@uib.es., Qayed WS; Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt. Electronic address: wesam.qayed@aun.edu.eg.

Publikováno v: Talanta [Talanta] 2022 Jan 01; Vol. 236, pp. 122890. Date of Electronic Publication: 2021 Sep 20.

Poly (bromocresol green) flakes-decorated pencil graphite electrode for selective electrochemical sensing applications and pharmacokinetic studies.

Autor: Gadallah MI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt. Electronic address: mohamedabrahim@pharm.aun.edu.eg., Ali HRH; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt., Askal HF; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt., Saleh GA; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt.

Publikováno v: Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2019 Sep; Vol. 102, pp. 634-645. Date of Electronic Publication: 2019 Mar 23.